Background: In the present randomized study, we evaluated the differential effects of a colloid and a crystalloid fluid on renal oxygen delivery (RD O2 ), glomerular filtration (GFR), renal oxygen consumption (R _ VO 2 ), and the renal oxygen supply-demand relationship (i.e. renal oxygenation) after cardiac surgery with cardiopulmonary bypass. Methods: Thirty patients with normal preoperative renal function, undergoing uncomplicated cardiac surgery, were studied in the intensive care unit in the early postoperative period. Patients were randomized to receive a bolus dose of either a crystalloid (Ringers-acetate ® 20 ml kg
carries a mortality between 50 and 80% and is associated with high hospital costs. [5] [6] [7] Furthermore, increasing evidence suggests that a minor elevation in serum creatinine after cardiac surgery is an independent risk factor for increased mortality and for prolonged stay in the intensive care unit and in hospital. 6 8 9 The pathogenesis of cardiac surgery-associated AKI involves a variety of pathways. 10 Impaired renal oxygen delivery (RD O2 ), causing ischaemic tubular cell injury, has been considered to be one of the main mechanisms underlying postcardiac surgery AKI. 11 A decreased oxygen delivery may be caused by haemodilution-induced anaemia and intraoperative hypotension together with low postoperative cardiac output, in turn caused by heart failure or hypovolaemia. 3 12-14 The renal medulla, particularly the outer portion, is on the verge of hypoxia even in normal conditions. This is caused by the high utilization of oxygen of the medullary thick ascending limb and a relative medullary hypoperfusion, when compared with the cortex. The outer portion of the renal medulla is therefore particularly sensitive to impaired RD O2 . 15 I.V. fluids, such as colloids or crystalloids, are commonly used for treatment of postoperative hypovolaemia after cardiac or other major surgery, to prevent or ameliorate early AKI. 16 However, even though i.v. fluids may increase cardiac output and renal blood flow (RBF), they will also decrease arterial oxygen content by haemodilution, with potentially no or minor beneficial net effects on RD O2 . Indeed, recent animal studies have shown that colloids or crystalloids do not increase RD O2 despite increases in cardiac output and that crystalloids, in contrast to colloids, may impair regional renal microvascular oxygenation. 17 18 To our knowledge, the effects of i.v. fluids on RD O2 and renal oxygenation have not been studied in postoperative patients after major surgery. Furthermore, perioperative data on the differential effects of crystalloids vs colloids with respect to RBF, RD O2 , glomerular filtration rate (GFR), renal oxygen consumption (R _ VO 2 ), and renal oxygenation, defined as the renal oxygen supply-demand relationship, are lacking. We therefore performed a randomized study to evaluate the differential renal effects of bolus doses of a crystalloid and a colloid. In the present study, we tested the null hypothesis that there is no difference between a crystalloid and a colloid with respect to changes in RD O2 and renal oxygenation after major surgery.
Methods

Patients
The study protocol was approved by the Gothenburg Regional Ethics Committee (www.epn.se). Written informed consent was obtained from each patient before the operation. The study was registered in ClinicalTrials.gov, identifier: NCT01729364. The inclusion criteria were as follows: (i) age >18 yr; (ii) elective coronary artery bypass surgery with cardiopulmonary bypass; (iii) preoperative normal serum creatinine; (iv) left ventricular ejection ≥40%; and (v) attainment of target levels of central venous pressure (5-10 mm Hg), mean arterial pressure (MAP; >70 mm Hg), and mixed venous oxygen saturation ðSv O2 ; >60%) before randomization, according to our local clinical treatment protocol. The exclusion criteria were as follows: (i) combined cardiac surgery procedures; (ii) excessive postoperative bleeding (>100 ml h −1 ); (iii) intra-or postoperative need for inotropic or vasoactive support or diuretics (furosemide, mannitol); or (iv) hypotension because of arrhythmias. Premedication consisted of oxazepam (10 mg) and oxycodone (10 mg). Anaesthesia was induced by fentanyl (5-10 µg kg ). Before and after cardiopulmonary bypass, anaesthesia was maintained with sevoflurane (0.5-2.5%) in a 50% O 2 -air mixture. During cardiopulmonary bypass, anaesthesia was maintained with an i.v. infusion of propofol (2-4 mg kg
). The pump was primed with acetated Ringer's solution (1300 ml) without mannitol. Normothermic, non-pulsatile cardiopulmonary bypass was performed at a flow of 2.4 litres min −1 m −2 and a target haematocrit of 20-25%. In the intensive care unit, the patients were sedated with propofol (1.5-3.6 mg kg −1 h −1 ) and morphine
) and mechanically ventilated.
Systemic haemodynamics
Arterial blood pressure was measured continuously via a radial or femoral artery catheter. A pulmonary artery thermodilution catheter (Baxter Healthcare Corporation, Irvine, CA, USA) was used for measurements of central venous pressure, pulmonary artery and wedge pressures and cardiac output. Bolus measurements of thermodilution cardiac output were performed in triplicate and indexed to the body surface area for cardiac index (CI). Systemic vascular resistance index, pulmonary vascular resistance index, and stroke volume index (SVI) were calculated according to standard formulae. 
Measurements of renal variables
Experimental procedure
The experimental procedure was performed 4-6 h after the end of cardiopulmonary bypass when the patients had a stable body
Editor's key points
• Acute kidney injury is one major postoperative complication after cardiac surgery with cardiopulmonary bypass, and it is not known whether or not there are differences in renal oxygen delivery between plasma volume expansion with crystalloid and colloid.
• In a randomized design, effects on renal oxygen delivery and other renal factors were compared between plasma volume expansion with crystalloid and colloid.
• Neither colloid nor crystalloid improved renal oxygen delivery, but crystalloid, but not colloid, increased the GFR with impaired renal oxygenation. 
Statistical analysis
To detect a relative difference of 25% in RD O2 or renal oxygen extraction with a power of 80% and a two-sided significance level of 0.05, at a standard deviation of 24 ml min −1 and 0.024, respectively, 30 patients would be required (15 patients in each group), based on data from a previous study. 23 To compensate for dropouts, we aimed to include ∼40 patients. Intragroup effects of the colloid and crystalloid solutions, respectively, were determined by one-way  for repeated measurements. Differences between groups were compared using an analysis of covariance () for repeated mesurements, using the mean of the two baseline measurements (C1 and C2) as a covariate. This statistical approach adjusts for baseline differences between groups. Categorical data were compared using Fisher's exact test. A P-value <0.05 was considered significant. PASWStatistics 18.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analyses. Data are presented as mean and standard deviation () of the mean.
Results
Informed consent was obtained from 39 patients the day before surgery. The clinical trial profile is shown in Figure 1 . Thirty patients were randomized after renal vein catheterization to receive either a colloid (n=15) or a crystalloid solution (n=15). There were no significant differences between the two groups with respect to preoperative characteristics, as presented in Table 2 . There were no significant differences between the groups at baseline (C1 and C2), before fluid administration, in any of the measured or calculated variables (Tables 3 and 4) . Randomized to colloid n=15 Randomized to crystalloid n=15
Unsuccessful catheterisation of the renal vein n=3
Fulfilled inclusion criteria and informed consent obtained (n=39)
Surgery cancelled n=2 Need for inotropic support n=2 Declined on the day of surgery n=1 Considered non-eligible by the surgeon n=1 Effects of i.v. fluids on systemic haemodynamics, arterial oxygen content, and systemic oxygen delivery (Table 3) As expected, both fluids induced haemodilution, with significant decreases in haematocrit and Ca O2 . There was a peak 9% increase in MAP at 20 min after the end of fluid infusion in the crystalloid group, after which MAP declined towards baseline. In the colloid group, there was a consistent 12-15% increase in MAP. A 16-18% peak increase in CI and SVI were seen after 20 min in the crystalloid group, followed by a decline towards baseline. In the colloid group, there was a consistent 18-23% increase in CI and SVI. An increase in CI of >10% was seen in 12 of 15 patients in the crystalloid group and 13 of 15 patients and colloid group, and 11 of 15 patients in both groups increased their CI by >15%. Left-and right-sided filling pressures increased, systemic vascular resistance index decreased, and heart rate was unaffected by the two fluids. There was a transient 10% increase in systemic oxygen delivery index in the crystalloid group at 40 min, whereas systemic oxygen delivery index was not affected in the colloid group.
Crystalloid vs colloid The decrease in haematocrit and arterial oxygen content was significantly greater after the fluid bolus administration in the colloid group. The increase in MAP was not significantly different between groups. The increase in CI was significantly higher in the colloid group, while changes in SVI or heart rate did not differ between groups. The increases in left-and right-sided filling pressures and mean pulmonary artery pressure were significantly higher in the colloid group during the experimental procedure. Increases in systemic oxygen delivery index and decreases in systemic vascular resistance index after fluid administration did not differ significantly between groups.
Effects of i.v. fluids on renal variables (Table 4) There was a transient 9% increase in RBF at 20 min in the crystalloid group, whreas there was a more consistent 11-17% increase in RBF in the colloid group. The ratio between RBF and CI (RBF/CI) 148 (21) 137 (22) 142 (22) 141 ( decreased with the crystalloid but not with the colloid. Renal vascular resistance was not affected in any of the groups. Bolus fluid administration did not affect RD O2 in any of the groups. The GFR and sodium filtration increased transiently with the crystalloid, with a peak 28% increase at 40 min. In the colloid group, GFR and sodium filtration were not significantly changed from baseline after fluid administration. In the crystalloid group, tubular sodium reabsorption increased transiently, with a peak increase of 23% at 40 min, whereas in the colloid group tubular sodium reabsorption did not change significantly from baseline. The filtration fraction (FF) increased transiently in the crystalloid group (24% at 40 min), with no changes in the colloid group. Urine flow increased in both groups. The R _ VO 2 increased (by 16-21%) in the crystalloid group, with no changes in the colloid group. Renal vein oxygen saturation decreased and arterial-renal vein oxygen content difference increased in the crystalloid group, whereas these variables were not affected in the colloid group. Renal oxygen extraction, a direct measure of the renal oxygen supply-demand relationship, increased by 23% in the crystalloid group, whereas the colloid bolus did not affect renal oxygen extraction Figure 2 .
Crystalloid vs colloid The increase in urine flow was significantly higher in the crystalloid group. The increase in FF in the crystalloid group differed significantly from the change in the colloid group. In the crystalloid group, changes in renal vein oxygen saturation, renal oxygen extraction, and arterial-renal vein oxygen content difference were significantly higher than in the colloid group. There was a trend for a higher increase in R _ VO 2 in the crystalloid group (P=0.085) and a higher increase in RBF in the colloid group (P=0.089). There were no significant intergroup differences in RD O2 , GFR, renal vascular resistance, RBF/CI, sodium filtration, or sodium reabsorption. 
Discussion
We studied the renal effects of acute plasma volume expansion with artificial solutions early after cardiac surgery. The main findings were that, despite apparent increases in cardiac index and RBF with both fluids, neither of the fluids increased RD O2 . Furthermore, plasma volume expansion with the crystalloid impaired the renal oxygen supply-demand relationship, expressed as a more pronounced increase in renal oxygen extraction compared with the colloid. The lack of effect on RD O2 , despite the increase in RBF with both fluids, is explained by the fact that the arterial oxygen content decreased in both groups as a result of plasma volume expansion and haemodilution. In addition, the crystalloid bolus seemed to redistribute blood flow away from the kidneys, as reflected by the reduction in the RBF/CI ratio. Thus, the increase in RBF was not in proportion to the increase in CI with the crystalloid.
One important difference between the two fluids was their differential effects on the renal oxygen supply-demand relationship. The R _ VO 2 increased in the crystalloid group, which was not matched by a proportional increase in RD O2 , as indicated by the increase in renal oxygen extraction. In contrast, R _ VO 2 , RD O2 , and renal oxygen extraction were not affected by the colloid. Our group has repeatedly shown in postoperative patients that the major determinant of R _ VO 2 is GFR. An increase in glomerular sodium filtration will increase the sodium reabsorption, which, in turn, will increase R _ VO 2 . 19 20 24 Also in the present study, the increase in glomerular sodium filtration was associated with increases in sodium reabsorption and R _ VO 2 in the crystalloid group. In the colloid group, however, this chain of events was not observed, as the colloid did not affect GFR.
Infusion of a bolus dose of an isotonic crystalloid, such as the acetated Ringer's solution used in the present study, redistributes within 20-30 min to the interstitial fluid space because of the short (8-10 min) distribution half-life. 25 26 Thus, a bolus dose of a crystalloid induces only a transient increase in plasma volume, as also demonstrated by a return towards baseline of haematocrit, cardiac filling pressures, and CI within 60 min in the present study, in contrast to the colloid group. Thus, to maintain the plasma volume in an expanded state in the treatment of postoperative hypovolaemia, repeated bolus doses of a crystalloid are required, with a potential for each of the crystalloid boluses to impair renal oxygenation in a hypovolaemic patient already subjected to impaired RD O2 and potentially also renal medullary ischaemia.
In the present study, we measured the renal extraction of 51 Cr-EDTA, which is a direct measure of the renal FF ( i.e. the GFR/RPF ratio). The FF increased with the crystalloid, suggesting that the increase in GFR (and R _ VO 2 ) was not matched by a proportional increase in renal blood flow. We have previously shown in postoperative cardiac surgery patients that there is a close positive correlation (r 2 >0.81) between the renal FF and renal oxygen extraction. 19 20 Thus, the crystalloid-induced increase in FF supports our finding of a renal oxygen supply-demand impairment with a crystalloid. 19 20 27 Our data are in line with previous animal studies. Thus, in an experimental study on Merino cross-ewes, it was shown that both a crystalloid and a colloid infusion, if anything, reduced RD O2 , because of haemodilution, despite increased cardiac output. 17 Furthermore, in a rat hypovolaemic shock model, saline for treatment of hypovolaemia did not improve RD O2 or renal microvascular P O2 . 28 In a recent experimental study, it was shown that acute normovolaemic haemodilution with a crystalloid decreased renal microvascular oxygenation in the cortex and outer medulla, in contrast to a colloid (hydroxethyl starch 6% 130/0.4), which maintained regional renal microvascular oxygenation. 18 Haemodilution with the crystalloid was also associated with highest formation of tissue oedema and highest expression of hypoxia-inducible factor-1α, in their study. In the present study, both fluids increased cardiac index. In the colloid group, the increase in CI was more pronounced and consistent during the experimental procedure. One could therefore argue that a larger bolus dose of the crystalloid, e.g. 30 ml kg −1 , would have induced a more pronounced increase in CI, RBF, and renal oxygen delivery, with less or no impairment of the renal oxygen demand-supply relationship. On the contrary, a higher dose of the crystalloid would have induced a more pronounced haemodilution, which would have counteracted a beneficial increase in RBF, with potentially no net increase in RD O2 . Furthermore, a higher dose of the crystalloid would decrease the oncotic pressure further, potentially increasing GFR and R _ VO 2 to a greater extent than with a lower dose of crystalloid. Thus, it is not immediately evident that a higher dose (e.g. 30 ml kg −1 ) of a crystalloid than the one used in the present study would have had a less negative effect on the renal oxygen demand-supply relationship.
One limitation of the present study was that we included patients who were considered haemodynamically stable, according to our local postoperative treatment protocol. Thus, we did not measure arterial pulse pressure or stroke volume variation to assess fluid responsiveness. 28 29 The reason for this approach is that we considered it unethical to include patients with obvious haemodynamic signs of hypovolaemia, defined by our clinical protocol, without treating this condition during the preparation for the experimental procedure, including time to reach a body temperature >36°C, time needed for serum 51 Cr-EDTA to reach steady state (at least 60 min), and baseline measurements (60 min) before start of the plasma volume expansion. However, 80-90% of the patients in both groups responded to the plasma volume by an increase in CI. 29 30 We therefore strongly believe that our results on the renal effects of colloid and crystalloid solutions are valid for a group of patients undergoing major surgery, responding to plasma volume expansion with an increase in CI in the early postoperative period.
In conclusion, we evaluated the differential renal effects of a colloid and a crystalloid early after cardiac surgery. Although both fluids increased CI and RBF, neither of the fluids improved renal oxygen delivery. The crystalloid-induced increase in GFR was associated with impaired renal oxygen demand-supply relationship, not seen with the colloid. Treatment of hypovolaemia with a bolus dose of a crystalloid therefore has the potential to impair renal oxygenation in postoperative patients.
